POSA40 Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) Versus Tiotropium Monotherapy in Patients with COPD in the UK von Martin, A, Shah, D, Shukla, S, Kendall, R, Risebrough, NA, Compton, C, Ismaila, A

Volltext

Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources von Hoogendoorn, Martine, Feenstra, Talitha L, Boland, Melinde, Briggs, Andrew H, Borg, Sixten, Jansson, Sven-Arne, Risebrough, Nancy A, Slejko, Julia F, Rutten-van Mölken, Maureen Pmh

Volltext

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial von Halpin, David MG, Kendall, Robyn, Shukla, Soham, Martin, Alan, Shah, Dhvani, Midwinter, Dawn, Beeh, Kai M, Kocks, Janwillem WH, Jones, Paul W, Compton, Chris, Risebrough, Nancy A, Ismaila, Afisi S

Volltext

Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective von Shah, Dhvani, Risebrough, Nancy A, Perdrizet, Johnna, Iyer, Neeraj N, Gamble, Cory, Dang-Tan, Tam

Volltext

Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model von Shukla, Soham, Shah, Dhvani, Martin, Alan, Risebrough, Nancy A., Kendall, Robyn, Vogelmeier, Claus F., Boucot, Isabelle, Tombs, Lee, Bjermer, Leif, Jones, Paul W., Kerwin, Edward, Compton, Chris, Maltais, Francois, Lipson, David A., Ismaila, Afisi

Volltext

Estimation Of Direct And Indirect Costs Associated With Asthma And Copd: A Canadian Employers Perspective von Ng, C, Risebrough, NA, Jayasundara, KS, Freeman, MA

Volltext

PRS30 - Estimation Of Direct And Indirect Costs Associated With Asthma And Copd: A Canadian Employers Perspective von Ng, C, Risebrough, NA, Jayasundara, KS, Freeman, MA

Volltext

Economic Evaluation of Oseltamivir Phosphate for Postexposure Prophylaxis of Influenza in Long-Term Care Facilities von Risebrough, Nancy A., Bowles, Susan K., Simor, Andrew E., McGeer, Alison, Oh, Paul I.

Volltext

ECONOMIC EVALUATION OF DALTEPARIN, ENOXAPARIN AND UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP VEIN THROMBOSIS von Risebrough, Na, Mittmann, N

Volltext

Health-related quality-of-life treatments for severe haemophilia: utility measurements using the Standard Gamble technique von NARAINE, V. S., RISEBROUGH, N. A., OH, P., BLANCHETTE, V. S., LEE, S., STAIN, A-M., HEDDEN, D., TEITEL, J. M., FELDMAN, B. M.

Volltext

MCI WHY DO DIFFERENT MODELS COME TO DIFFERENT CONCLUSIONS?: A STUDY OF 8 COST-EFFECTIVENESS ANALYSES COMPARING COX-2 SPECIFIC INHIBITORS (COXIBS) AND NON STEROIDAL ANTI-INFLAMMATOR... von Risebrough, NA, Drummond, M, Neumann, P, Using, A, Mittmann, N, Niculescu, L

Volltext

PAR3 TESTING THE BMJ CHECKLIST AS A QUALITY ASSESSMENT TOOL FOR ECONOMIC EVALUATIONS von Drummond, M, Neumann, P, Risebrough, NA, Lising, A, Mittmann, N, Niculescu, L

Volltext

CV6: ECONOMIC EVALUATION OF DALTEPARIN, ENOXAPARIN AND UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP VEIN THROMBOSIS von Risebrough, NA, Mittmann, N

Volltext

CEB8: A DECISION ANALYTIC MODEL MEASURING THE COST-EFFECTIVENESS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN HIV+ PATIENTS WITH HIGH VERSUS LOW BASELINE VIRAL LOAD: AN INDIN... von Risebrough, NA, Oh, P, Rachlis, A, McMurchy, D, Bast, M, Doswell, M

Volltext

Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model von Briggs, AH, Baker, T, Risebrough, NA, Chambers, M, Gonzalez-McQuire, S, Ismaila, AS, Exuzides, A, Colby, C, Tabberer, M, Muellerova, H, Locantore, N, Rutten-van Mölken, MPMH, Lomas, DA

Volltext bestellen